Top Back to top

Graft-versus-Host Disease after donor-derived chimeric antigen receptor T-cell infusion post allogeneic HSCT

Transplant Complications Working Party (TCWP)
Cellular Therapy & Immunobiology Working Party (CTIWP)
Type d'étude:
Numéro de l'étude:
Type de traitement à base de cellules souches:
Titre court:
Chronic GVHD over time
Objectif principal:
To determine cumulative incidence of acute and chronic GvHD at 100 and 365 days, after donor-derived CAR T-cell infusion post allo-HSCT.
Principaux critères d'inclusion:
Recipients of Allogeneic HSCT; Disease Relapse after Allogeneic HSCT; Donor derived CAR T-cell infusion after Allogeneic HSCT.
Investigateur principal:
Guillermo Ortí